Cargando…
Repurposing picropodophyllin as a potential thyroid eye disease treatment via delaying mitotic clonal expansion through a patient‐derived preclinical platform
Autores principales: | Hu, Jing, Wu, Jiali, Jin, Qihuang, Zhang, Ling, Shen, Ning, Shu, Yiyang, Cheng, Lu, Zhang, Jian, Hu, Guangyi, Lv, Kangjia, Jian, Qizhi, Chen, Hui, Zhang, Fang, Sun, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070929/ https://www.ncbi.nlm.nih.gov/pubmed/37012693 http://dx.doi.org/10.1002/ctm2.1218 |
Ejemplares similares
-
Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy
por: Lv, Kangjia, et al.
Publicado: (2022) -
Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism
por: Waraky, Ahmed, et al.
Publicado: (2014) -
FTO influences adipogenesis by regulating mitotic clonal expansion
por: Merkestein, Myrte, et al.
Publicado: (2015) -
Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)
por: Hashemi, Jamileh, et al.
Publicado: (2011) -
Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
por: TOMIZAWA, MINORU, et al.
Publicado: (2014)